Roos van Westrhenen

1.8k total citations · 1 hit paper
40 papers, 1.1k citations indexed

About

Roos van Westrhenen is a scholar working on Pharmacology, Nephrology and Pharmacology. According to data from OpenAlex, Roos van Westrhenen has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Nephrology and 10 papers in Pharmacology. Recurrent topics in Roos van Westrhenen's work include Pharmacogenetics and Drug Metabolism (12 papers), Dialysis and Renal Disease Management (10 papers) and Treatment of Major Depression (7 papers). Roos van Westrhenen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Dialysis and Renal Disease Management (10 papers) and Treatment of Major Depression (7 papers). Roos van Westrhenen collaborates with scholars based in Netherlands, United Kingdom and United States. Roos van Westrhenen's co-authors include Iris E. Sommer, Marieke Begemann, René S. Kahn, Lot D. de Witte, Stefan Leucht, Raymond T. Krediet, Machteld M. Zweers, S.A. Steenen, Ad de Jongh and Jan de Lange and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Schizophrenia Bulletin and Nephrology Dialysis Transplantation.

In The Last Decade

Roos van Westrhenen

37 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics

2023 71 citations Marga Nijenhuis, Bianca Soree et al. European Journal of Human Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roos van Westrhenen Netherlands	15	270	244	236	199	146	40	1.1k
Britta Haenisch Germany	20	180 0.7×	160 0.7×	63 0.3×	29 0.1×	167 1.1×	52	1.9k
Carol R. Reed United States	16	309 1.1×	144 0.6×	165 0.7×	22 0.1×	342 2.3×	27	1.5k
Tuncer Çaycı Türkiye	20	40 0.1×	77 0.3×	104 0.4×	97 0.5×	215 1.5×	71	1.0k
Ankur Jindal India	22	30 0.1×	152 0.6×	139 0.6×	101 0.5×	139 1.0×	121	2.0k
Emin Özgür Akgül Türkiye	20	47 0.2×	78 0.3×	64 0.3×	35 0.2×	127 0.9×	68	1.0k
Seyed Hesameddin Abbasi Iran	18	77 0.3×	65 0.3×	50 0.2×	45 0.2×	190 1.3×	70	1.5k
John Meijer Netherlands	18	229 0.8×	222 0.9×	49 0.2×	13 0.1×	96 0.7×	29	1.9k
Daniel Kopf Germany	21	225 0.8×	121 0.5×	15 0.1×	45 0.2×	78 0.5×	77	1.3k
Bryan Shapiro United States	12	106 0.4×	106 0.4×	14 0.1×	193 1.0×	51 0.3×	25	733
Michael Skinner United States	16	207 0.8×	40 0.2×	187 0.8×	74 0.4×	412 2.8×	25	1.4k

Countries citing papers authored by Roos van Westrhenen

Since Specialization

Citations

This map shows the geographic impact of Roos van Westrhenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roos van Westrhenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roos van Westrhenen more than expected).

Fields of papers citing papers by Roos van Westrhenen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roos van Westrhenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roos van Westrhenen. The network helps show where Roos van Westrhenen may publish in the future.

Co-authorship network of co-authors of Roos van Westrhenen

This figure shows the co-authorship network connecting the top 25 collaborators of Roos van Westrhenen. A scholar is included among the top collaborators of Roos van Westrhenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roos van Westrhenen. Roos van Westrhenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serretti, Alessandro, Giuseppe Nicolò Fanelli, Bernhard T. Baune, et al.. (2025). Polygenic scores and antidepressant treatment outcomes in major depression: a critical integrative review. Neuroscience Applied. 4. 105530–105530.

Fares‐Otero, Natalia E., Monika Budde, Mathias Harrer, et al.. (2025). Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis. European Neuropsychopharmacology. 100. 13–23. 1 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas. European Journal of Human Genetics. 33(4). 413–420. 2 indexed citations

Manson, Lisanne E. N., Marga Nijenhuis, Bianca Soree, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs. European Journal of Human Genetics. 32(8). 903–911. 8 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants. European Journal of Human Genetics. 32(11). 1371–1377. 6 indexed citations

Amelsvoort, Thérèse van, et al.. (2024). Clinical effects of CYP2D6 phenoconversion in patients with psychosis. Journal of Psychopharmacology. 38(12). 1095–1110.

Philipsen, Alexandra, Allan H. Young, Mário F. Juruena, et al.. (2024). A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study. Pharmaceuticals. 17(2). 151–151. 8 indexed citations

Nijenhuis, Marga, Bianca Soree, Nienke J. de Boer‐Veger, et al.. (2023). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. European Journal of Human Genetics. 32(3). 278–285. 71 indexed citations breakdown →

Westrhenen, Roos van, et al.. (2023). Pharmacogenomics and the Management of Mood Disorders—A Review. Journal of Personalized Medicine. 13(7). 1183–1183. 1 indexed citations

10.

Fabbri, Chiara, Danyang Li, Roos van Westrhenen, et al.. (2023). The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank. Pharmaceuticals. 16(9). 1277–1277. 12 indexed citations

11.

Pisanu, Claudia, Giovanni Severino, Ilario De Toma, et al.. (2022). Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review. European Neuropsychopharmacology. 55. 112–157. 11 indexed citations

12.

Steenen, S.A., Roos van Westrhenen, Jan de Lange, & Ad de Jongh. (2022). Updated and rectified meta-analysis shows no effect of propranolol versus placebo on traumatic memory reconsolidation disruption. Journal of Psychiatry and Neuroscience. 47(5). E336–E337. 3 indexed citations

13.

Westrhenen, Roos van, Ron H. N. van Schaik, Teun van Gelder, et al.. (2021). Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice. Frontiers in Pharmacology. 12. 640032–640032. 22 indexed citations

14.

Brouwer, J., Marga Nijenhuis, Bianca Soree, et al.. (2021). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs. European Journal of Human Genetics. 30(10). 1114–1120. 78 indexed citations

15.

Wierdsma, André I., et al.. (2021). The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study. CNS Drugs. 35(4). 451–460. 4 indexed citations

16.

Steenen, S.A., Arjen J. van Wijk, Geert J. M. G. van der Heijden, et al.. (2015). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology. 30(2). 128–139. 154 indexed citations

17.

Sommer, Iris E., Roos van Westrhenen, Marieke Begemann, et al.. (2013). Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update. Schizophrenia Bulletin. 40(1). 181–191. 253 indexed citations

18.

Westrhenen, Roos van, Machteld M. Zweers, Cindy Kunne, et al.. (2008). A Pyruvate-Buffered Dialysis Fluid Induces Less Peritoneal Angiogenesis and Fibrosis than a Conventional Solution. Peritoneal Dialysis International. 28(5). 487–496. 24 indexed citations

19.

Michels, Wieneke M., Machteld M. Zweers, Watske Smit, et al.. (2004). Does Lymphatic Absorption Change with the Duration of Peritoneal Dialysis?. Peritoneal Dialysis International. 24(4). 347–352. 27 indexed citations

20.

Krediet, Raymond T., Machteld M. Zweers, Roos van Westrhenen, Marja M. Ho-dac-Pannekeet, & Dirk G. Struijk. (2003). What Can We Do to Preserve the Peritoneum?. Peritoneal Dialysis International. 23(2_suppl). 14–19. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact